AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹35 Cr | ₹29 Cr | ₹32 Cr | ₹35 Cr | ₹44 Cr |
What is the latest Contingent Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹35 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹44 Cr |
How is Contingent Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹35 Cr | 22.25 | |
| Mar2024 | ₹29 Cr | -11.91 | |
| Mar2023 | ₹32 Cr | -8.19 | |
| Mar2022 | ₹35 Cr | -19.47 | |
| Mar2021 | ₹44 Cr | - | |
Compare Contingent Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹245.3 Cr | -1.1% | 2.3% | -11.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,639.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,647.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,366.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,528.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,819.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -1.1% |
2.3% |
-11.4% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses